|
C1QBP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.46939954332504E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.27029999963391E-07 |
| Normal-vs-Stage2 |
5.542400E-02 |
| Normal-vs-Stage3 |
1.071780E-02 |
| Normal-vs-Stage4 |
1.343390E-01 |
| Stage1-vs-Stage2 |
6.017200E-01 |
| Stage1-vs-Stage3 |
8.432600E-01 |
| Stage1-vs-Stage4 |
6.430000E-01 |
| Stage2-vs-Stage3 |
7.589800E-01 |
| Stage2-vs-Stage4 |
5.021600E-01 |
| Stage3-vs-Stage4 |
6.015200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.81030004717553E-09 |
| Normal-vs-AfricanAmerican |
4.391200E-04 |
| Normal-vs-Asian |
2.379200E-01 |
| Caucasian-vs-AfricanAmerican |
5.275800E-01 |
| Caucasian-vs-Asian |
6.177800E-01 |
| AfricanAmerican-vs-Asian |
4.275200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.12389999926432E-08 |
| Normal-vs-Female |
1.69436999999384E-05 |
| Male-vs-Female |
4.871200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.114380E-02 |
| Normal-vs-Extreme_Weight |
2.12410000000052E-05 |
| Normal-vs-Obese |
3.821600E-04 |
| Normal-vs-Extreme_Obese |
1.533230E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.205800E-01 |
| Normal_Weight-vs-Obese |
9.615800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.447400E-01 |
| Extreme_Weight-vs-Obese |
8.336600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.676400E-01 |
| Obese-vs-Extreme_Obese |
6.221000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.740000E-02 |
| Normal-vs-Age(41-60Yrs) |
5.44419999970458E-07 |
| Normal-vs-Age(61-80Yrs) |
5.58969999953085E-07 |
| Normal-vs-Age(81-100Yrs) |
8.140400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.657400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.212000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.989700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.193600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.325600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.155170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.0490003551148E-10 |
| Normal-VS-Type2 PRCC |
6.831400E-04 |
| Normal-VS-KIRP CIMP |
1.291240E-01 |
| Normal-VS-Unclassified PRCC |
3.495700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.095000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.512600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.512600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.074400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.761200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.262400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.630400E-02 |
| Normal-vs-N1 |
3.695500E-03 |
| Normal-vs-N2 |
4.788800E-01 |
| N0-vs-N1 |
3.585800E-01 |
| N0-vs-N2 |
2.026400E-01 |
| N1-vs-N2 |
5.784000E-02 |
|
|
